Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis.
about
Cardiac regeneration: epicardial mediated repairProtocol for a systematic review of screening tools for fear of recurrent illness in common life-threatening diseasesCancer risk related to low-dose ionizing radiation from cardiac imaging in patients after acute myocardial infarctionQuality of care after acute coronary syndromes in a prospective cohort with reasons for non-prescription of recommended medicationsClosing the mortality gap after a myocardial infarction in people with and without chronic obstructive pulmonary diseaseAssociation between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use prior to major elective surgery and the risk of acute dialysisAnother treatment gap: restarting secondary prevention medications: the Women's Health Initiative.Temporal trends in medical therapies for ST- and non-ST elevation myocardial infarction: (from the Atherosclerosis Risk in Communities [ARIC] Surveillance Study)Renal function at the time of a myocardial infarction maintains prognostic value for more than 10 yearsRecent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI.Association of long-term adherence to evidence-based combination drug therapy after acute myocardial infarction with all-cause mortality. A prospective cohort study based on claims data.Age-related differences in factors associated with the underuse of recommended medications in acute coronary syndrome patients at least one year after hospital dischargeRacial and geographic variation in coronary heart disease mortality trends.30-year trends in heart failure in patients hospitalized with acute myocardial infarction.Sex differences in mortality after acute myocardial infarction: changes from 1994 to 2006.Statin use following hospitalization among Medicare beneficiaries with a secondary discharge diagnosis of acute myocardial infarctionThirty-year (1975 to 2005) trends in the incidence rates, clinical features, treatment practices, and short-term outcomes of patients <55 years of age hospitalized with an initial acute myocardial infarction.Association between myocardial infarction and fractures: an emerging phenomenonGrowth in medicare expenditures for patients with acute myocardial infarction: a comparison of 1998 through 1999 and 2008Efficacy of Long-Term β-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery.Trends in the incidence, treatment, and outcomes of acute lower extremity ischemia in the United States Medicare population.Beneficiaries with cardiovascular disease and thePart D coverage gap.Primary prevention of heart failure.Role of disease risk scores in comparative effectiveness research with emerging therapiesAssociations between body fat variability and later onset of cardiovascular disease risk factorsVariation in initiating secondary prevention after myocardial infarction by hospitals and physicians, 1997 through 2004Effect of exposure to evidence-based pharmacotherapy on outcomes after acute myocardial infarction in older adults.Cohorts based on decade of death: no evidence for secular trends favoring later cohorts in cognitive aging and terminal decline in the AHEAD study.Sternal insufficiency fracture related to steroid-induced osteoporosis: A case report.Case definitions for acute myocardial infarction in administrative databases and their impact on in-hospital mortality rates.National trends in stroke after acute myocardial infarction among Medicare patients in the United States: 1999 to 2010What is the effect of area size when using local area practice style as an instrument?Effect of evidence-based drug therapy on long-term outcomes in patients discharged after myocardial infarction: a nested case–control study in Italy"I'm not just a heart, I'm a whole person here": a qualitative study to improve sexual outcomes in women with myocardial infarction.Long term survival after evidence based treatment of acute myocardial infarction and revascularisation: follow-up of population based Perth MONICA cohort, 1984-2005Similar mortality rates in hip fracture patients over the past 31 years.Evaluation of proper prescribing of cardiac medications at hospital discharge for patients with acute coronary syndromes (ACS) in two Lebanese hospitals.Validity of claims-based definitions of left ventricular systolic dysfunction in Medicare patients.Ventricular tachycardia in ischemic heart disease substratesImpact of Visit-to-Visit Variability in Systolic Blood Pressure on Cardiovascular Outcomes in Korean National Health Insurance Service-National Sample Cohort.
P2860
Q26772102-4144CFC4-7319-4DE1-8EBC-00DAB528DE73Q26799416-2D84DCDA-8D25-4110-AEBA-8C3559010FA2Q28386694-6BB91D82-FE68-40D8-AACC-0F2A16E62942Q28541648-22C8885C-D961-4E92-82A6-B46E4D862749Q28646419-2255F4A9-17EC-4633-8CE4-EBAB0AB1AE2AQ33613082-EBE6E233-2170-4673-B7B4-6212D36ECA67Q33752799-A498397F-E419-46DE-9769-B77A31F6FA37Q33821081-1B36B6E5-0BCE-4C36-BFD6-390977B53B28Q33943876-A30532E2-87A2-467C-B7B4-E393F8CF7C17Q34025138-AC19946E-84E2-429F-B254-31FDCEFE4857Q34220461-378D7FB7-E461-42E5-83D2-2DAA97156E09Q34274017-931F4F2A-7809-43F3-8C91-454F6E522782Q34294607-3224A020-8629-4E0A-B7FE-192344697625Q34648516-5284BEBB-727A-4EF7-B52B-07979C93BE13Q35040735-54052A5B-1EA7-4D6B-94DF-D006424E56AAQ35135656-7E757D7E-6CD5-441F-824B-BA44E0FA6C9EQ35146193-DF308EC2-7ECF-45DE-96D0-2291202F6DABQ35162355-6EC7596B-C608-4CBF-B3C0-B525D6EE07A2Q35680070-AADEA027-F242-48D8-B359-C60D0F7B068CQ35755660-2EA2798D-56BE-410E-BFD4-4A982C1597B2Q35820827-FC3617D6-8EF1-43E5-BDB4-D35573AF63B4Q35992856-82735AF1-D2FA-469F-AC2D-D811F4CC70C5Q36200030-EA12DB5C-E783-4CB7-A1DE-EA4368628169Q36266471-7F47ADFD-379E-48A1-AA37-F6ED4406790DQ36331973-29B94E12-47CD-4B4F-8131-B03DAE83B2E9Q36468237-EA1733A7-CA83-41F2-BC00-EF27D5BE5504Q36521022-71CE9AE6-C7DC-4D23-924F-9719FCED4D11Q36528336-62619774-FE24-4D39-B99D-95D423C0A997Q36634749-AF522965-CFA8-467F-84F6-8CE72C75F42AQ36661519-DCBD4E14-F2A9-44D9-A7C6-3ED750730B91Q36775840-D511F2B0-5398-4502-96F3-8B4622CBCCFCQ37033997-E41B5743-CBA4-499A-943F-6BFFD5D706D9Q37101708-B0840AC9-5B7F-4602-89C0-D14C043CDCD0Q37310409-0A7CD57A-CC9E-4AB3-B44D-6374009D8CB8Q37402737-38D94986-69BD-4ABA-9063-92E01C76D1FFQ37614721-6690101D-12B9-4A44-BC7F-DDFE61FA4A9DQ37724877-8D2D37FA-D01F-493B-929E-095D07BFCA01Q37879071-24AA0566-DC8C-453F-8A5F-962F99AD8B18Q38191067-29E00D1F-9DBD-4207-9FF7-A94FDD2F4A6FQ38774804-C6A0B563-767C-41BF-839C-FB20E5F5F6BF
P2860
Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Improvements in long-term mort ...... rge: a 10-year trend analysis.
@en
Improvements in long-term mort ...... rge: a 10-year trend analysis.
@nl
type
label
Improvements in long-term mort ...... rge: a 10-year trend analysis.
@en
Improvements in long-term mort ...... rge: a 10-year trend analysis.
@nl
prefLabel
Improvements in long-term mort ...... rge: a 10-year trend analysis.
@en
Improvements in long-term mort ...... rge: a 10-year trend analysis.
@nl
P2093
P1476
Improvements in long-term mort ...... rge: a 10-year trend analysis.
@en
P2093
Jerry Avorn
Raisa Levin
Robert J Glynn
Soko Setoguchi
Wolfgang C Winkelmayer
P304
P356
10.1016/J.JACC.2007.10.063
P407
P577
2008-04-01T00:00:00Z